Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry
10.1186/s12885-016-2395-x
Saved in:
Main Authors: | , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/181363 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-181363 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-1813632023-10-31T20:54:53Z Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry De Groot, S Sleijfer, S Redekop, W.K Oosterwijk, E Haanen, J.B.A.G Kiemeney, L.A.L.M Uyl-de Groot, C.A SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH alpha interferon bevacizumab everolimus pazopanib sorafenib sunitinib temsirolimus antineoplastic agent indole derivative pazopanib pyrimidine derivative pyrrole derivative sulfonamide sunitinib adult age aged Article bone metastasis brain metastasis cancer prognosis cancer registry cancer survival clinical effectiveness clinical practice cohort analysis controlled study drug use drug utilization female high risk population human kidney carcinoma liver metastasis lung metastasis major clinical study male metastasis metastasis resection molecularly targeted therapy nephrectomy Netherlands number of metastatic site oncological parameters overall survival survival time systemic therapy trend study Carcinoma, Renal Cell Kidney Neoplasms middle aged molecularly targeted therapy prescription register retrospective study statistical model survival analysis treatment outcome very elderly young adult Adult Aged Aged, 80 and over Antineoplastic Agents Carcinoma, Renal Cell Drug Prescriptions Female Humans Indoles Kidney Neoplasms Logistic Models Male Middle Aged Molecular Targeted Therapy Netherlands Pyrimidines Pyrroles Registries Retrospective Studies Sulfonamides Survival Analysis Treatment Outcome Young Adult 10.1186/s12885-016-2395-x BMC Cancer 16 1 364 2020-10-27T10:41:57Z 2020-10-27T10:41:57Z 2016 Article De Groot, S, Sleijfer, S, Redekop, W.K, Oosterwijk, E, Haanen, J.B.A.G, Kiemeney, L.A.L.M, Uyl-de Groot, C.A (2016). Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry. BMC Cancer 16 (1) : 364. ScholarBank@NUS Repository. https://doi.org/10.1186/s12885-016-2395-x 14712407 https://scholarbank.nus.edu.sg/handle/10635/181363 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031 |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
topic |
alpha interferon bevacizumab everolimus pazopanib sorafenib sunitinib temsirolimus antineoplastic agent indole derivative pazopanib pyrimidine derivative pyrrole derivative sulfonamide sunitinib adult age aged Article bone metastasis brain metastasis cancer prognosis cancer registry cancer survival clinical effectiveness clinical practice cohort analysis controlled study drug use drug utilization female high risk population human kidney carcinoma liver metastasis lung metastasis major clinical study male metastasis metastasis resection molecularly targeted therapy nephrectomy Netherlands number of metastatic site oncological parameters overall survival survival time systemic therapy trend study Carcinoma, Renal Cell Kidney Neoplasms middle aged molecularly targeted therapy prescription register retrospective study statistical model survival analysis treatment outcome very elderly young adult Adult Aged Aged, 80 and over Antineoplastic Agents Carcinoma, Renal Cell Drug Prescriptions Female Humans Indoles Kidney Neoplasms Logistic Models Male Middle Aged Molecular Targeted Therapy Netherlands Pyrimidines Pyrroles Registries Retrospective Studies Sulfonamides Survival Analysis Treatment Outcome Young Adult |
spellingShingle |
alpha interferon bevacizumab everolimus pazopanib sorafenib sunitinib temsirolimus antineoplastic agent indole derivative pazopanib pyrimidine derivative pyrrole derivative sulfonamide sunitinib adult age aged Article bone metastasis brain metastasis cancer prognosis cancer registry cancer survival clinical effectiveness clinical practice cohort analysis controlled study drug use drug utilization female high risk population human kidney carcinoma liver metastasis lung metastasis major clinical study male metastasis metastasis resection molecularly targeted therapy nephrectomy Netherlands number of metastatic site oncological parameters overall survival survival time systemic therapy trend study Carcinoma, Renal Cell Kidney Neoplasms middle aged molecularly targeted therapy prescription register retrospective study statistical model survival analysis treatment outcome very elderly young adult Adult Aged Aged, 80 and over Antineoplastic Agents Carcinoma, Renal Cell Drug Prescriptions Female Humans Indoles Kidney Neoplasms Logistic Models Male Middle Aged Molecular Targeted Therapy Netherlands Pyrimidines Pyrroles Registries Retrospective Studies Sulfonamides Survival Analysis Treatment Outcome Young Adult De Groot, S Sleijfer, S Redekop, W.K Oosterwijk, E Haanen, J.B.A.G Kiemeney, L.A.L.M Uyl-de Groot, C.A Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry |
description |
10.1186/s12885-016-2395-x |
author2 |
SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH |
author_facet |
SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH De Groot, S Sleijfer, S Redekop, W.K Oosterwijk, E Haanen, J.B.A.G Kiemeney, L.A.L.M Uyl-de Groot, C.A |
format |
Article |
author |
De Groot, S Sleijfer, S Redekop, W.K Oosterwijk, E Haanen, J.B.A.G Kiemeney, L.A.L.M Uyl-de Groot, C.A |
author_sort |
De Groot, S |
title |
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry |
title_short |
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry |
title_full |
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry |
title_fullStr |
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry |
title_full_unstemmed |
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry |
title_sort |
variation in use of targeted therapies for metastatic renal cell carcinoma: results from a dutch population-based registry |
publishDate |
2020 |
url |
https://scholarbank.nus.edu.sg/handle/10635/181363 |
_version_ |
1781792487457685504 |